St. Louis, MO, United States of America

Kay Broschat

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Corporation. Active years: 2005.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kay Broschat - Innovator in Enzyme Activity Assays

Introduction

Kay Broschat is a notable inventor based in St. Louis, MO (US). She has made significant contributions to the field of enzyme activity assays, particularly through her innovative patent. Her work is essential for advancing research in enzyme kinetics and pharmaceutical drug development.

Latest Patents

Kay Broschat holds a patent for an "Ion-exchange resin/enzyme activity assay." This invention relates to a rapid high-throughput ion-exchange resin assay for determining enzyme activity. The novel assay employs a radiometric technique that separates the radioactive substrate from the product by exploiting the differences in the net charges of the molecules using ion-exchange resin. This assay is particularly useful for studies of enzyme kinetics, identifying functional sites in enzymes, and automating the screening of compound libraries for drug development.

Career Highlights

Kay is currently associated with Pharmacia Corporation, where she applies her expertise in enzyme assays. Her innovative approach has positioned her as a key figure in her field, contributing to advancements in biochemical research.

Collaborations

Throughout her career, Kay has collaborated with esteemed colleagues such as Thomas P Kasten and Mark G Currie. These partnerships have further enhanced her research and development efforts.

Conclusion

Kay Broschat's contributions to enzyme activity assays exemplify her innovative spirit and dedication to scientific advancement. Her work continues to impact the fields of biochemistry and pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…